Company / Operating Cash Flow per Share
Corbus Pharmaceuticals Holdings, Inc. Operating Cash Flow per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$11.56
FY2022
5-year range
-$11.56 / -$0.50
FY2018-FY2022
Trend
-1045.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -1046% YoY in FY2022, a notable deviation from the 7-year average annual change of -210%.
Based on SEC 10-K filings.
-11.56 in FY2022.
Declined from $-0.71 to $-11.56 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Corbus Pharmaceuticals Holdings, Inc.'s operating cash flow per share has declined for 5 consecutive years.
- In FY2022, operating cash flow per share decreased 1045.9% year-over-year.
- Peak operating cash flow per share was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$11.56 | -1045.9% |
| FY2021 | -$1.01 | -42.6% |
| FY2020 | -$0.71 | -34.6% |
| FY2019 | -$0.53 | -5.1% |
| FY2018 | -$0.50 | -306.5% |
| FY2017 | -$0.12 | +0.0% |
| FY2016 | -$0.12 | -35.1% |
| FY2015 | -$0.09 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026